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Early development of infants with
neurofibromatosis type 1: a case series
Anna May Kolesnik1†, Emily Jane Harrison Jones1*†, Shruti Garg2, Jonathan Green2, Tony Charman3,
Mark Henry Johnson1 and the EDEN-BASIS Team+
Abstract
Background: Prospective studies of infants at familial risk for autism spectrum disorder (ASD) have yielded insights
into the earliest signs of the disorder but represent heterogeneous samples of unclear aetiology. Complementing
this approach by studying cohorts of infants with monogenic syndromes associated with high rates of ASD offers
the opportunity to elucidate the factors that lead to ASD.
Methods: We present the first report from a prospective study of ten 10-month-old infants with neurofibromatosis
type 1 (NF1), a monogenic disorder with high prevalence of ASD or ASD symptomatology. We compared data from
infants with NF1 to a large cohort of infants at familial risk for ASD, separated by outcome at age 3 of ASD (n = 34),
atypical development (n = 44), or typical development (n = 89), and low-risk controls (n = 75). Domains assessed at
10 months by parent report and examiner observation include cognitive and adaptive function, sensory processing,
social engagement, and temperament.
Results: Infants with NF1 showed striking impairments in motor functioning relative to low-risk infants; this pattern
was seen in infants with later ASD from the familial cohort (HR-ASD). Both infants with NF1 and the HR-ASD group
showed communication delays relative to low-risk infants.
Conclusions: Ten-month-old infants with NF1 show a range of developmental difficulties that were particularly
striking in motor and communication domains. As with HR-ASD infants, social skills at this age were not notably
impaired. This is some of the first information on early neurodevelopment in NF1. Strong inferences are limited by
the sample size, but the findings suggest implications for early comparative developmental science and highlight
motor functioning as an important domain to inform the development of relevant animal models. The findings
have clinical implications in indicating an important focus for early surveillance and remediation in this early
diagnosed genetic disorder.
Keywords: NF1, Infant, Translational neurodevelopment, Autism, Prospective longitudinal, Adaptive functioning,
Cognition, Sensory processing, Social engagement, Development
Background
Autism spectrum disorder (ASD) is a neurodevelopmen-
tal disorder that affects social communication and flex-
ible behaviour in up to 1.5% of the population [1].
Identifying causal paths that link genetic and environ-
mental risk factors to later behaviour is a critical target
for the field, because of the potential to yield new routes
to intervention. Symptoms of ASD likely emerge through
a complex developmental cascade of interactions between
genetics, the brain, cognition, behaviour, and the child’s
interaction with their environment [2]. ASD can be
reliably diagnosed by ages 2 to 3[3], and risk factors act
predominately prenatally [4, 5]. Thus, a focus on early
brain development is critical to differentiating putative
causal paths from compensatory, adaptive, or secondary
cascading effects of early symptoms [6]. Linking those
causal paths to specific neurobiological systems is critical
to developing new pharmacological treatments to comple-
ment existing behavioural therapies [7].
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Prospective longitudinal studies of infants with older
siblings with ASD have yielded significant insights into
its earliest features in this group [2]. In the first year of
life, behavioural differences in infants with later ASD are
difficult to detect and may be most common in sensory
and motor functioning [8, 9]. For example, 6-month-old
infants with later ASD are more likely to show poor
head control [10] and infants at familial risk as a group
show poor postural control [11] and more limited reaching
and grasping skills [12]. In contrast, social communication
appears relatively typical in the first 6 months [8, 13],
although neurocognitive measures reveal subtle vulnerabil-
ities in social engagement [14], response to eye gaze [15],
and declining interest in eyes [16]. By the end of the first
year, clear differences are present in a range of ASD-related
behavioural phenotypes, including poorer language and
communication skills [8], reduced joint attention [17],
diminishing social interest [13], and the emergence of
unusual interests in objects [18]. Measures like the Autism
Observational Scale for Infants begin to show reasonable
sensitivity to ASD outcome at this time [19, 20], although
diagnosis is still difficult until the second or third year of life
[3]. Thus, it appears that clear delays in ASD-relevant
domains emerge over the first year of life but may be
preceded by alterations in early brain development that
affect lower-level sensorimotor systems.
The unclear aetiology of ASD in infants at polygenic
familial risk makes it difficult to translate such insights
to animal models, which are mainly based on single gene
knock-out approaches. This in turn limits our ability to
tie insights to particular neurobiological systems or
pathways and to generate new pharmacological treat-
ment strategies. A complementary way to study the
emergence of ASD that may facilitate translational insights
is to test infants with defined genetic syndromes associ-
ated with a heightened incidence of ASD. Examples of
conditions that can be potentially identified in early devel-
opment, carry a high risk of ASD, and have been success-
fully modelled in animals include fragile X syndrome,
tuberous sclerosis complex, and neurofibromatosis type 1
(NF1). One challenge to this approach is that these condi-
tions are rare. Identified genetic syndromes only account
for a small proportion of cases of ASD, and thus, the gen-
eralisability of mechanisms observed in particular disor-
ders remain unclear [21, 22]. Thus, the optimal strategy
may be to establish which antecedent biomarkers
observed in studies of infants at familial risk are also
present in infants with genetic syndromes. In this way, we
can identify generalised causal paths that are likely widely
applicable but that can also be more carefully probed at
the molecular and neurobiological levels.
Prospective studies of infants with NF1 provide an
important complementary approach in this context. In
contrast to other monogenic syndromes, NF1 is not
complicated by severe intellectual disability or seizures.
NF1 is the most common autosomal-dominant single-
gene condition associated with increased risk for neuro-
developmental disorders, with birth incidence of 1:2700
[23]. Fifty percent of the cases are inherited, while the
rest are de novo cases due to spontaneous mutation of
the NF1 gene located on chromosome 17q11.2, which
encodes for the protein neurofibromin. Although well
known for its cutaneous manifestations, the main chal-
lenges experienced by people with NF1 are cognitive,
social, and behavioural. The overall IQ is in the low-
average range, although specific learning impairments
are common [24]. There is a high prevalence of ASD in
NF1, with rates of 25% full ASD and 20% with partial
ASD symptoms in the pediatric NF1 population [25].
The phenotypic profile of ASD in NF1 is also broadly
similar to idiopathic ASD [26], making insights from
NF1 more likely to generalise to understanding ASD
more broadly.
The downstream molecular consequences of impaired
NF1 function have been well characterised in NF1 knock-
out mouse models [27]. Impaired disinhibition of the Ras/
MAP kinase pathway leads to changes in synaptic pro-
teins, GABA/glutamate disequilibrium, and impairments
in synaptic function [28]. Further, abnormalities in cyclic
AMP and dopamine homeostasis underlie the attention
system abnormalities in NF1 [29]. The social learning and
attention impairments characteristic of ASD have been re-
capitulated in NF1 knock-outs [28, 30]. Targeted treat-
ments such as lovastatin [31] and lamotrigine [32] reverse
the NF1-associated cognitive impairments in knock-
out models, but translational clinical trials in humans have
so far had mixed results [33]. A major impediment for
clinical trials is the lack of sensitive outcome measures on
which to target treatment and a poor understanding of
neurodevelopmental trajectories in children with NF1.
Longitudinal studies mapping the developmental trajec-
tories of children with NF1 will allow inferences
about causal mechanisms as well as identify candidate bio-
markers for future intervention studies. Treatments tar-
geted in the prodromal period (before behavioural
symptoms of ASD and ADHD emerge) could prevent or
ameliorate the later emergence of symptoms [34].
Diagnosis of NF1 is made on clinical assessment using
the National Institute of Health clinical consensus cri-
teria. Since 50% of the cases are inherited, NF1 can be
diagnosed in infancy using cord blood mutation testing
or on clinical assessment. The comparison of develop-
mental levels between infants with NF1 and infants with
older siblings with ASD (defined on familial risk status)
is thus putatively less confounded by ascertainment bias
than for other comparable syndromes. Unless there are
parental concerns, most infants with NF1 do not receive
routine developmental monitoring. To our knowledge,
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this is the first study to report the developmental profile
of NF1 in infancy.
Present study
To understand early developmental profiles and the emer-
gence of behaviours related to ASD in infants with NF1,
we recently launched a prospective longitudinal study of
this population. Our projected group size will be 30
infants with data on a rich battery of behavioural and neu-
rocognitive measures at 5, 10, 14, 24, and 36 months; this
report represents the first ten infants with data at
10 months enrolled in the study. This is a particularly
interesting age, because it appears to mark the beginning
of the emergence of behavioural signs of ASD in infants at
familial risk [2]. The present study had two goals: first, to
determine what developmental areas might be affected by
the NF1 mutation in early development, and second, to
examine whether infants with NF1 show profiles that
resemble those of infants who develop ASD through other
risk pathways. To do this, we compared the developmen-
tal profiles of infants with NF1 to those of a larger group
of infants at high familial risk for ASD with different
developmental outcomes at age 3 (typical development,
ASD, or other atypical developmental profiles), in addition
to a sample of low-risk typically developing infants. Taken
together, our study provides the first evidence of the pro-
file of developmental difficulties in infants with NF1 and
their similarities and differences to profiles observed in
infants at familial risk for ASD.
Methods
Participants
Participants described in this case series include ten 10-
month-old children (4 male; 6 female) with an NF1 diagno-
sis through the Early Development in Neurofibromatosis
Type 1 (EDEN) research project. NF1 is a rare disorder,
with a birth incidence of approximately one in 2700 births
in the UK per year [37]. Thus, our recruitment methods
aimed to maximise the representativeness of our sample
within the context of the rarity of the disorder. Participants
were recruited via local and regional genetic centers (Man-
chester, Leeds, Newcastle, Southampton) and via advertise-
ments placed in the NF charities’ social media webpages.
The study has R&D approval for recruitment across all spe-
cialist genetic centers across the UK. The study information
was offered to eligible participants at routine clinical
appointments. Within the general population, NF1 is
approximately 50% familial and 50% sporadic [35].Our
sample consists primarily of familial cases (8/10) because
they are typically identified earlier in development through
cord blood testing. Of note, our previous behavioural phe-
notyping studies have shown no differences between famil-
ial and de novo cases [26].
All of the participants who had inherited NF1 were
confirmed via molecular testing of cord blood samples
(n = 8) or clinical diagnosis based on NIH consensus
criteria (n = 2) [36]. Six of the infants had at least one
older sibling. Behavioural and cognitive profiles of these
infants were compared to a large corpus of data from
the British Autism Study of Infant Siblings (BASIS,
phases 1 and 2; http://basisnetwork.org). These children
either had a family history of ASD and went onto receive
a diagnosis at 36 months (HR-ASD, n = 34, 8F), had
other indications of atypical development (such as high
scores on ASD-related symptom measures or poor
cognitive development; HR-Atyp, n = 43, 20F), or were
typically developing (HR-no ASD, n = 89, 44F); or were
‘low-risk’ controls, i.e. had no family history of ASD (LR,
n = 72, 37F). ASD diagnoses were made at age 3 years for
research purposes only through expert clinical judgment
based on all available clinical and behavioural assess-
ments (including gold-standard ADOS and ADI mea-
sures) collected at 24 and 36 months (for details, see
Additional file 1). The study was approved by the Na-
tional Research Ethics Service London Central Ethical
Committee and conducted in accordance with the Dec-
laration of Helsinki (1964). As the study is ongoing, it is
not yet possible to estimate how many of the children
with NF1 will go on to receive an ASD diagnosis.
Procedures
Informed consent was obtained from all families. All
assessments took place at the Centre for Brain and
Cognitive Development, Birkbeck, London. Behavioural
measures described below were administered as part of a
more extensive experimental protocol; for summary, see
Additional file 1: Table S1.
Cognitive and adaptive skills
Cognitive ability was assessed through the Mullen Scales
of Early Learning (M) administered according to the man-
ual [37]. This is an observational measure that assesses
gross and fine motor skills, expressive and receptive
language, and visual reception. We report t scores per
subdomain (M = 50, SD = 10), based on the US norms.
Adaptive skills were assessed using the Vineland Adaptive
Behavior Scale Parent Survey (VABS; [38]) form, a parent-
report questionnaire that assesses socialisation, communi-
cation, motor behaviour, and daily living skills. We report
standard scores per domain (M = 100, SD = 15) based on
the US norms.
ASD symptoms
The Autism Observation Scale for Infants (AOSI; [39,
40]) is a 19-item interactive play schedule and was
administered to five of the infants. It is designed to
monitor early signs of ASD and measure aspects of
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visual attention, social communication, and development
of sensory and motor skills. Absence/presence of behav-
iours is rated 0–3, where 0 signifies normal function,
and higher values suggests increasing deviation from the
normal behaviour expected at the age of assessment.
Total scores range from 0–50 [19, 41].
Temperament
Parents completed the Infant Behavior Questionnaire
(IBQ [42]), a parent-report measure that comprises 14
subscales grouped into three overarching factors labelled
Surgency (the child’s tendency to show excitement, posi-
tive affect, and approach), Negative Affect (the child’s
tendency to cry, be avoidant, or otherwise fussy), and
Effortful Control (the child’s ability to regulate their
mood and behaviour) [42, 43]. Parents of infants at high
familial risk for ASD completed the original form of the
IBQ-R [44]; parents of infants with NF1 completed the
short form [42]. For comparability between cohorts, we
rescored the long form of the IBQ-R by only selecting
items also included on the short form.
Sensory processing
Parents completed the Infant/Toddler Sensory Profile
(ITSP [45]). This questionnaire produces scores in four
quadrants that reflect the child’s responsiveness to differ-
ent types of sensory experiences. Sensation Seeking
(generating higher sensory input for oneself ) and Low
Registration (noticing fewer sensory cues) encompass
high-threshold responses. Sensory Sensitivity and Sensa-
tion Avoiding reflect low-threshold responses and are
combined into a low-threshold quadrant score (detecting
more sensory input than others, with negative affect and
low self-regulation). Further, the scale includes five sen-
sory processing scores for different processing systems
(e.g. visual, auditory, tactile). Norms are available, and
score ranges for typical performance or probable or def-
inite differences are provided per subscale.
Examiner-rated behaviour
Levels of social engagement (SE) were examined through
consensus coding of six different aspects of infant behav-
iour, including social affect, temperament, and vocalis-
ing; researchers used a 7-point Likert Scale at the end of
the testing day ([46]; see Additional file 1).
Analytic strategy
We first present case vignettes for each infant. For mea-
sures with available norms (Mullen, VABS, and ITSP),
we interpret scores as below average (< − 1SD) or low (<
− 2SD) based on common convention using terminology
specific to each measure. Sensory behaviours measured
through the ITSP were rated as either probably more/
less than others if one standard deviation away from the
mean and definitely more/less than others when the
score is two standard deviations away; note that cut-off
scores vary per subdomain for this measure [45]. We
also report qualitative summaries of non-standardised
measures (IBQ, SE). However, it is important to note that
all measures were administered in a research, not clinical
context, and thus should not be considered diagnostic.
Second, we compared the performance of infants with
NF1 at a group level with our other cohorts (HR-TD,
HR-Atyp, HR-ASD, and LR) using ANCOVA with age as
a covariate.
Results
Case summaries
Acronyms are used to identify the source of information
provided about their level of cognitive/sensory development
(e.g. IBQ, VABS). Descriptive data and scores are presented
in Additional file 1: Tables S2, S3, S4, S5, and S6.
Case 1: male, diagnosis of NF1, at 10 months
Significant delays in gross motor skills (M, VABS), for
example, he was not able to move from sitting to hands
and knees, roll over, or pull up from supine to a sitting
position. Fine motor abilities were below average for the
age group, as he demonstrated a partial pincer grasp but
could not take blocks in/out of a container or bang them
together (M). Cognitive skills were within the average
range (M). Infant demonstrated object permanence,
appropriate use of objects, and understanding inhibitory
commands. Expressive language was below average and
consisted of voluntary babbling and consonant sounds,
with no first words or jabbering with inflection (M);
receptive language was adequate, but he had difficulty
understanding verbal requests and questions from the
examiner (M). Broader communication skills were
moderately low (VABS). Social skills were a relative
strength and judged at age-expected levels (VABS).
Examiners reported moderate levels of eye contact and
attentiveness, but relatively low levels of shared affect
(SE). He showed altered sensory processing across all
domains relative to age-appropriate norms (particularly
auditory, vestibular, and oral processing); this mainly
reflected more registration of sensory stimuli and a low
threshold for noticing sensory changes (ITSP). By parent
report of temperament, surgency, negative affect, and
effortful control were all within one standard deviation
of average values in the low-risk sample (IBQ).
Case 2: male, diagnosis of NF1, at 11 months
Gross motor skills were within the normal range by exam-
iner observation (M), and he had strong fine motor skills
(M); he had mastered balance and control of the upper/
lower extremities and was gaining upright mobility. How-
ever, his overall adaptive motor skills were rated lower than
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average by parent report (e.g. sitting and crawling behav-
iours occurred lower relative to the age-matched popula-
tion norm). Cognitive skills were a relative strength—he
achieved object permanence and demonstrated early spatial
awareness and visual memory (M). Communication skills
were relatively poor, specifically in receptive language; he
was able to understand simple verbal input (e.g. response
to own name or familiar names/words) but failed to give a
toy in response to a request and a gesture or identify an
object after hearing it named (M). Expressive language was
in the average range, marked by presence of first word, as
well as communication of intentions through jargon com-
bined with gestures. By parent report, his everyday commu-
nication behaviour was relatively strong, as were his social
skills (e.g. responding to parent with vocalisation, engaging
in games of ‘peek-a-boo’; VABS). Examiners reported fre-
quency of eye contact, shared affect, and social responsive-
ness (SE). Temperamentally, his surgency and negative
affect were within the normal range (though he showed
high activity levels in the lab SE), but he showed relatively
lower levels of effortful control than low-risk infants (IBQ).
Sensory processing was considered typical for most do-
mains, though he showed probably altered auditory pro-
cessing and definitely less sensation seeking than other
infants (ITSP).
Case 3: male, diagnosis of NF1, at 11 months (*)
Gross motor skills were very low (unable to sit inde-
pendently), and fine motor skills were below average
(M): he was able to grasp and manipulate objects, as well
as display a partial pincer grasp, but was not able to use
both hands together when playing with an object or turn
pages in a book. Parent report suggests his use of motor
skills in everyday life was adequate but gross motor skills
were poorer than fine motor skills (VABS). He had
marked difficulty in controlling motor behaviour, although
no atypical motor/sensory behaviours specifically related
to ASD were noted (AOSI). Cognitive skills were in the
low-average range (M); he showed object permanence and
began associating objects with functions but was unable
to open/close a book or pay attention to pictures. Expres-
sive language skills were very low; he did not babble or
produce consonant sounds during the assessment (M).
Receptive language was also below average; he was able to
give a toy on request, but only when it was accompanied
by a gesture, and was not able to understand simple ques-
tions from the experimenter (M). During the AOSI, he
showed no social babbling. However, by parent report, his
communication skills at home were adequate (VABS) and
his social skills were strong (VABS). During the day, the
child was rated as moderately socially responsive, with
moderate eye contact and shared affect (SE), but he
showed clearly atypical eye contact, reciprocal smiling,
and social interest when probed (AOSI). Temperament
was parent-rated as comparable to other groups for sur-
gency and negative affect, but effortful control was lower
than in low-risk controls (> − 1SD) (IBQ); examiners also
rated him as moderately negative and quite active (SE).
Sensory ratings indicated altered visual processing, and
definitely ‘less’ low registration (meaning he was less likely
to fail to notice sensory stimuli in the environment).
Case 4: male, diagnosis of NF1, at 12 months
Gross motor skills were very low for his age group (M,
VABS). He was unable to pull up on furniture or get into
a sitting position from hands and knees (M). Fine motor
abilities were age-appropriate—he was able to use both
hands to manipulate an object and displayed finer coord-
ination of movement (M). Cognitive scores were a relative
strength; he obtained object permanence and early spatial
awareness and could associate an object and its function
(M). Expressive language was very low—he was unable to
voluntarily babble or produce any consonant sounds (M).
He also showed below-average receptive language ability
and was unable to identify an object or respond to a verbal
request (M). By parent report, his communication skills
were just in the average range. Daily living and social skills
were adequate (VABS); examiners also rated his eye con-
tact, affect, and social responsiveness as frequency (SE).
Surgency and effortful control were within one standard
deviation of the typical range (IBQ), and examiners rated
his temperament as very positive (SE); however, by parent
report, he showed elevated negativity relative to low-risk
controls (IBQ). Sensory sensitivity was within the typical
range for all scores, apart from probably altered sensitivity
to vestibular sensations (items include needs support for
sitting, enjoying physical play, and resists having head
tipped back).
Case 5: female, diagnosis of NF1, at 9 months (*)
Gross motor skills were below average in the lab (M) and
low in everyday contexts (VABS). Fine motor skills were
below average; she was able to use a partial pincer grip,
but not both hands together, or turn pages in a book
sequentially (M). During the AOSI, she showed marked
difficulty controlling motor behaviour, as well as atypical
sensory and motor behaviours (AOSI). Cognitive skills
were very delayed, with partial object tracking, no object
permanence, and failure to associate objects with func-
tions (M). However, by parent report, her daily living skills
were typical (VABS). Communication skills were delayed
(VABS); during testing, her receptive language skills were
rated as below average, while expressive language was a
relative strength and age-appropriate, with voluntary
babbling and production of several words (M). Everyday
social skills were below average (VABS); however, during
the testing day, the child maintained relatively frequent
eye contact and shared affect with the experimenter (SE)
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and showed good social skills on the AOSI. Temperamen-
tally, her surgency (e.g. expression of pleasure) and nega-
tivity were within expected levels but effortful control was
rated lower than low-risk controls (< − 1SD; IBQ). The
child showed pervasive atypicalities in the sensory domain,
with atypical auditory, visual, tactile, and oral sensory be-
haviours; these were likely related to more low registration
(reduced attention towards environmental cues; ITSP).
Case 6: female, diagnosis of NF1, at 10 months
Gross motor abilities were at floor level in the lab (M),
equivalent to a 3-month-old (M). Child was able to bear
weight on forearms and hold her head steady in a sup-
ported seated position but was not able to roll over or
grasp fingers and pull up from a supine into a sitting
position. However, she performed at an ‘above average’
level on fine motor skills (M); adaptive fine motor skills
were low but in the average range (VABS), showing evi-
dence of the development of more precise coordination of
movement. Visual reception skills were age-appropriate,
for example, she achieved object permanence and was
able to associate objects with functions (M). Expressive
language was within the average range; she produced var-
ied and controlled vocalisations and was able to say one
recognisable word (M); receptive language skills were
below average (M). Parent ratings also indicated moder-
ately low communication abilities (VABS) but relatively
strong social skills. During the testing day, she showed fre-
quent eye contact, moderate shared affect, and social
responsiveness. Temperamentally, she was rated during
the testing day as showing a highly positive temperament
though with low attentiveness (SE), and by parent report,
surgency, negativity, and effortful control scores were
within the average range of control groups (IBQ). Finally,
she showed no overt atypicalities in sensory behaviours
across all domains (ITSP).
Case 7: female, diagnosis of NF1, at 10 months (*)
Gross motor skills and adaptive motor behaviours were
below average for the age range, but fine motor skills
were typical (M, VABS) and she showed no motor atypi-
calities on the AOSI. She had good cognitive ability, in-
cluding object permanence, early spatial awareness and
visual memory (M). Language skills were poor, with low
expressive language; she showed voluntary babbling and
production of consonants but was unable to vocalise
two-syllable sounds or produce first words as expected
for the age group (M). She showed very poor receptive
language (the 5-month level); she did not respond to her
name or understand simple verbal input. Adaptive com-
munication skills were considered strong by parent
report (VABS). Social skills in everyday contexts were
also typical by parent report (VABS); during testing, she
showed frequent eye contact, moderate shared affect,
and social responsiveness but became distressed when
without her parents. She showed some evidence of di-
minished social responsiveness to an unfamiliar exam-
iner when promoted (A). Temperamentally, surgency
and effortful control were low (< − 1SD) and negative
affect was high (> + 2SD) relative to typical controls,
although was rated as relatively active and attentive (SE).
Sensory responses were altered for auditory and visual
domains, likely because she is more likely to notice less
sensory cues from the immediate environment (ITSP).
Case 8: female, diagnosis of NF1, at 10 months (*)
Gross motor functioning was poor; she was unable to
pull herself to stand or move from sitting position to
hands and knees (M); this was accompanied by atypical
motor control and behaviours, such as hand waving
(AOSI). She also showed poor fine motor skills and was
unable to manipulate objects or demonstrate a pincer
grasp (M); adaptive motor function was also rated low
by parents (VABS). Cognitive skills were below average
(although an area of relative strength), with partial object
permanence (M), and poor disengagement (AOSI). Lan-
guage skills were also significantly delayed in both
expressive and receptive domains (M) and in everyday
contexts (VABS). She was unable to voluntarily babble
or produce consonant sounds and showed absent
responses to sound or voice/face of the experimenter
(M). Social skills in an everyday context were also
delayed (VABS). In the lab, she showed moderate to
poor eye contact but poor shared affect and social
responsiveness (AOSI; SE). Temperamentally, her levels
of surgency were relatively low (> − 1SD), as was her
effortful control (IBQ). During the testing day, she
showed low attentiveness and activity level (SE). Parent-
rated reports indicated atypical sensory behaviours
across auditory and visual/vestibular and oral sensory
domains, mainly related to higher levels of failing to
notice sensory stimuli as well as a higher likelihood to
have a low threshold for distress reactions (ITSP).
Case 9: female, diagnosis of NF1, at 11 months
Gross motor function was poor; she could sit independ-
ently but was not able to walk with one hand held or
stand up independently (M). Fine motor skills were typ-
ical, including using both hands together and coordi-
nated movements (M); composite motor skills in an
everyday context were low to average (VABS). Cognitive
skills were below average—she was able to show object
permanence and appropriate use of objects but failed to
pay attention to pictures shown by experimenter (M).
Expressive language skills were very low, with no volun-
tary babbling or consonant sounds (M). Receptive lan-
guage was just below average, including giving a toy in
response to a verbal request and understanding actions
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(i.e. waving goodbye or clapping). Overall adaptive com-
munication was rated as adequate (VABS). Social skills
were also rated as adequate (VABS), and during the day,
she showed frequent eye contact, shared affect, and gen-
erally positive temperament (SE). Temperamentally, she
showed low surgency and negative affect (< 1SD) relative
to low-risk controls; effortful control was high (> 1SD).
In the sensory domain, she showed a broadly typical
profile, with altered visual processing, probably less like-
lihood of failing to notice sensory stimuli and probably
more sensation seeking (ITSP).
Case 10: female, diagnosis of NF1, at 11 months (*)
Gross motor abilities were low, though she was able to
sit independently and turn to reach a toy placed on the
side (M). Fine motor skills were also below average,
including a partial pincer grasp and object manipulation;
however, she was unable to use both hands together or
turn pages in a book (M). Adaptive motor skills at home
were in the normal range by parent report (VABS), but
she showed atypical motor control and behaviours dur-
ing interaction with an examiner (AOSI). Her visual
reception skills were low-average, though she under-
stood object permanence and simple problem solving
(M). Expressive language was below average; she is able
to babble voluntarily but could not produce consonant
sounds and first words or engage in a gesture/language
game such as ‘peek-a-boo’ (M). She was functioning at a
very low range on receptive language; she did not
respond to own name or understand simple verbal input
(M). Adaptive communication skills were moderately
low by parent report (VABS). Social skills were within
the typical range; in the lab, she showed relatively
frequent eye contact, but limited shared affect and social
responsiveness and social babbling (SE, AOSI). Tem-
peramentally, she showed relatively high levels of nega-
tive affect (> 2SD), low effortful control (< 2SD), and
high surgency (> 1SD) (IBQ). Sensory behaviours were
within the typical range (ITSP).
Group analysis
Motor skills
There was a significant main effect of group on motor
(Vineland Motor and Mullen Fine and Gross Motor) skills
(F(12,624.7) = 6.36, p < .001, η2 = 0.097; with age covaried
F(12,622.043) = 5.86, p < .001, η2 = 0.090). This reflected
differences across Gross Motor (F(4,238) = 10.16,
p < .001, η2 = 0.15) and Fine Motor subscales of the
Mullen (F(4,238) = 6.28, p < .001, η2 = 0.096) and adaptive
Motor skills on the VABS (F(4,238) = 9.28, p < .001,
η2 = 0.14; see Figs. 1 and 2). Bonferroni-corrected pairwise
comparisons revealed that infants with NF1 showed
significantly lower scores on Gross Motor skills on the
Mullen relative to all four comparison groups (all ps < .01).
Infants with NF1 showed significantly lower Fine Motor
scores than the LR (p = 0.006) and HR-no ASD group
(p = 0.009) but not the HR-Atyp (p = 0.5) or HR-ASD
(p = 1) groups. On the VABS Motor domain, they showed
lower scores than LR (p = 0.003) and marginally the HR-
no ASD (p = .009) group but were comparable to the HR-
Atyp (p = 1) and HR-ASD group (p = 0.93). The HR-ASD
group also showed significantly lower scores than the LR
group for the VABS motor domain (p = 0.033), Mullen
fine motor skills (p = 0.012), and marginally Mullen gross
motor scores (p = 0.099). Thus, both infants with NF1
and the HR-ASD group showed significantly poorer motor
skills than low-risk infants.
Cognitive skills
There was a significant main effect of group on cognitive
(Mullen visual reception and VABS Daily Living) skills
(F(8,474) = 2.99, p = 0.003, η2 = 0.048; with age covaried
(F(8,472) = 3.08, p = 0.002, η2 = 0.05). This group effect
was seen for both Visual Reception (F(4,238) = 4.22,
p = 0.003, η2 = 0.066) and Daily Living scales
(F(4,238) = 2.78, p = 0.028, η2 = 0.045; see Figs. 1 and 2).
Bonferroni-corrected pairwise comparisons revealed that
infants with NF1 showed significantly lower Visual
Reception scores than the LR group (p = 0.022), margin-
ally lower than the HR-no ASD group (p = 0.11) but not
the HR-Atyp (p = 1) or HR-ASD (p = 1) groups. Daily
Living Skills were comparable to all other groups
(p = 1). The HR-ASD group showed significantly lower
scores for Daily Living Skills than the LR group
(p = 0.033); this was not the case for Visual Reception
(p = 0.3). Inspection of the means in Fig. 2 indicates
that infants with NF1 showed comparable values to
the HR-ASD group; thus, the absence of clear group
differences may be related to the smaller size of that
group.
Language
There was a significant main effect of group on language
(Mullen Expressive and Receptive Language and VABS
Communication) skills (F(12,624.7) = 5.25, p < 0.001,
η2 = 0.081; with age covaried (F(12,622.043) = 5.82,
p < 0.001, η2 = 0.090). This reflected differences across
Receptive Language (F(4,238)= 7.42, p < 0.001, η2 = 0.11),
Expressive Language (F(4,238) = 6.03, p < 0.001, η2 = 0.09),
and adaptive Communication (F(4,238) = 6.02, p < 0.001,
η2 = 0.092; see Figs. 1 and 2). Bonferroni-corrected pairwise
comparisons revealed that infants with NF1 showed signifi-
cantly lower scores for Receptive Language than low-risk
infants (p = 0.001) and the HR-TD (p < 0.001) and HR-
Atyp (p = 0.007) groups but not the HR-ASD (p = 0.17)
groups. For expressive language, infants with NF1 showed
significantly lower scores than all other groups (ps ≤ 0.001).
For Vineland Communication scores, the NF1 group
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showed significantly lower scores than LR infants only
(p = 0.025; other groups ps > 0.3). The HR-ASD group
showed significantly lower scores than the HR-no ASD
group for receptive language (p = 0.007) than the LR group
for VABS Communication (p = 0.025); other comparisons
were not significant (ps > 0.3). Thus, both infants with NF1
and the HR-ASD group showed lower communication
scores than LR infants.
Social functioning
There were no significant group differences in Vineland so-
cialisation scores (F(4,239) = 2.063, p = 0.086, η2 = 0.033).
We did not compute statistical comparisons for the AOSI,
since only five infants with NF1 completed it, but the
distribution of scores within the NF1 group appeared simi-
lar to those for the HR-ASD group (Fig. 3).
Temperament
There were no significant group differences on the IBQ
(F(12,622.043) = 1.25, p = 0.24, η2 = 0.021).
Discussion
We present the first developmental profiles of in-
fants with NF1 and compare them to a large cohort
of infants at familial risk with later ASD. Our initial
report was designed to address two questions. First,
what are the developmental challenges experienced
by infants with NF1? Second, how do those
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challenges compare to infants with other familial
routes to ASD? Findings reveal developmental delays
across multiple domains that show some intriguing
similarities to the pattern of difficulties seen in in-
fants with familial risk routes to ASD.
Developmental difficulties experienced by infants with NF1
Infants with NF1 showed broad developmental difficul-
ties across a number of cognitive and motor domains.
The most consistently affected areas were motor and
communication skills, for which delays relative to low-
risk infants were observed across both the Mullen and
the Vineland. In addition, seven of the ten infants
showed atypical scores on at least one domain of sensory
responsivity, though the nature of the atypicality was
heterogeneous. Similar developmental problems are
observed in other genetic disorders linked to ASD, like
Fragile X (FXS). For example, Hogan and colleagues
report a case series of eight infants with FXS followed
from 9 to 24 months of age, half of whom later met cri-
teria for ASD [43]. Many infants showed relatively high
levels of emergent autism-like behaviours on the Autism
Observational Scale for Infants (AOSI), particularly
those with a later outcome of autism. By the end of the
first year, cognitive and adaptive deficits were seen in
almost all infants and did not appear to differ by autism
diagnosis. Thus, early developmental delays may be a
common feature in infants with genetic syndromes
linked to ASD.
Recent research has shown that the NF1 gene muta-
tion confers a general vulnerability for cognitive difficul-
ties in the preschool period. A study of 40 children with
NF1 aged 3–6 years found weaker cognitive abilities on
all subscales of the Differential Ability Scales compared
to controls matched for age and socioeconomic status
[47]. At least a third of preschool children with NF1
have difficulties with expressive and receptive language
skills as well as phonological awareness [48]. A cross-
sectional study of 39 toddlers with NF1 aged 21–
30 months assessed using Bayley Scales of Infant Devel-
opment, Wechsler preschool scale of intelligence, and
parental measures of behaviour found poorer cognitive,
motor, and language development in the NF1 group
compared to age-matched controls [49]. Cognitive devel-
opment was in the low to average range, 1 SD lower
than controls, with below-average motor development in
a third of the cohort. Further, parental responses indi-
cated delayed receptive and expressive language develop-
ment in over 70% of the NF1 cohort. Our current data
indicates that these delays observed in preschoolers are
present from at least 10 months of age and appear to be
more pronounced in infancy. Longitudinal follow-up of
our current cohort will be required to determine whether
delays partially resolve over time.
Clinical information suggests low rates of identification
of other co-occurring neurodevelopmental conditions
within children with NF1, with substantial ‘diagnostic
overshadowing’ in ascribing cognitive and behavioural
problems to the NF1 diagnosis alone [25]. Diagnostic
delays limit effectiveness of interventions, with life-long
impacts on social and occupational functioning [50, 51].
There is an urgent need to develop early assessment and
intervention approaches for ASD in NF1 that could
significantly improve developmental outcomes for chil-
dren. Our work indicates that developmental delays are
apparent from at least 10 months of age, and so, early
intervention may be particularly critical. Early
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quartile, and whiskers show full range). No statistical comparisons were carried out as the sample size for NF1 was too small. Asterisks (*) depict
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interventions are not routinely provided; current guide-
lines recommend developmental assessment in order to
support additional needs on starting school [52].
NF1 and familial routes to ASD
Some elements of the developmental profile of infants
with NF1 were similar to those seen in infants with
familial routes to ASD. On the Vineland Adaptive
Behavior Scales, socialisation profiles did not signifi-
cantly differ between infants with NF1, infants with later
ASD from familial risk cohorts, and low-risk infants.
Further, infants with NF1 were rated as having relatively
typical profiles of social engagement during the lab visit.
Our rating scale was adapted from one used within
infants with later ASD [46], and here too, infants were
rated as relatively engaged at this age, with scores
declining across the second year. It would be important
to see whether infants with NF1 display the same profile
of emerging social difficulties with age. At the group
level on the Vineland, children with later ASD from our
comparison samples showed the worst performance in
motor skills and the best in socialisation and daily living,
with communication skills at an intermediate level; the
group means for children with NF1 show the same pat-
tern albeit with more pronounced motor difficulties (see
also [8] for no differences in socialisation at 12 months
in infants at high familial risk for ASD). Longitudinal fol-
low-up will be required to determine whether a similar
profile is seen in the subgroup of infants with NF1 who
develop later ASD. Nonetheless, our work suggests that
relatively unaffected social functioning at the behavioural
level at 10 months may be a shared phenotype between
infants with both genetic and familial routes to ASD.
At the group level, developmental difficulties in in-
fants with NF1 were generally more pronounced
across all domains than in our comparison samples at
familial risk of ASD, including those who went on to
have an ASD outcome. This may be associated with
the generally low likelihood of intellectual disability in
samples of infants at familial risk relative to the
broader population of children with ASD [2]. Interest-
ingly, cognitive outcomes for children with NF1 tend
to be better than for other neurodevelopmental con-
ditions, so it will be important to determine whether
over time many children catch up (to a degree) with
their peers. Nonetheless, reports that the earliest be-
havioural signs related to later ASD are in motor skill (e.g.
head lag) and sensory functioning [8–10] is somewhat
consistent with the motor delays and atypical sensory
responsivity we observed in infants with NF1. One im-
portant next step is to understand whether these early
motor delays have cascading effects on later functioning
and whether they can be related to observations in animal
models of NF1. Interestingly, there is preclinical evidence
of a role of the NF1 gene in skeletal development and
growth [53] and normal muscle function [54]; further
work should establish whether this contributes to the
delays in gross motor skills seen in our infant cohorts.
Our children with later ASD from the familial risk
group showed comparable profiles on the Mullen and
Vineland. In contrast, children with NF1 generally showed
more impairment on the Mullen than the Vineland. Inter-
preting these effects is difficult because of differences in
the way the measures are administered. Possibly, parents
of children with NF1 are less likely to recognise develop-
mental difficulties. Further, some infants with NF1 did not
have older siblings (n = 4) and this may affect how parents
judge their early development. Another potential limita-
tion is that we made group-based comparisons to a histor-
ical cohort of data (in order to present data on autism
outcome) collected by different teams at the same site.
Any differences between measure administration by differ-
ent examiners would affect Mullen scores but not the
Vineland or IBQ, because identical parent report forms
were used across cohorts. Taken together, the consistent
identification of motor and communication delays across
both the Mullen and Vineland scales (despite their different
limitations) gives particular confidence to these findings.
Clinical implications
This initial case series is too preliminary for any defini-
tive clinical implication, but it should alert the clinical
community. Identification and early surveillance will
often concentrate initially on the clinical genetic and
neurocutaneous aspects. Our findings indicate an
important focus for early developmental assessment and
appropriate remediation in newly diagnosed NF1 infants.
Limitations and future directions
Data collection for our project is still ongoing, and we
do not yet know which of the infants with NF1 will later
meet criteria for ASD or show elements of the broader
ASD phenotype. Outcomes for children with genetic
syndromes are highly heterogeneous [21]. ASD is not
present in every child with NF1; many also develop
other co-occurring conditions like epilepsy, intellectual
disability, or severe attention problems. Thus, longitu-
dinal prospective studies that can tease out predictors of
these different outcomes are required. However, studying
children with NF1 as a group (rather than dividing the
group into those with and without ASD outcome) is the
closest comparison to animal modelling approaches
(which typically contrast NF1 knock-outs with wildtype).
Given the rarity of NF1, our sample size is also relatively
small, consistent with other recent reports on infants
with rare disorders [43], [55]. Although our recruitment
methods were designed to increase the likelihood that
our cases would be representative of the broader
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population with NF1 (by recruiting through all UK gen-
etic clinics), this remains a potential limitation to the
generalisability of our conclusions and indicates the im-
portance of continuing to build larger samples in this
field. Because there are no previous reports from pro-
spective studies of infants with NF1, it is impossible to
determine the extent to which our sample is representa-
tive of the broader population of infants with NF1 in
terms of ability level and outcome. Planned longitudinal
follow-up in toddlerhood will be necessary to address
this question. One potential difference is that within the
general population, 50% of cases of NF1 are familial and
50% are sporadic [35]. Within our sample, 8/10 cases were
familial and two infants had a de novo mutation identified
postnatally through clinical presentation (usually the pres-
ence of café au lait spots). This imbalance is because fa-
milial NF1 is detected much earlier in development
(through cord blood testing). Consistent with previous re-
ports in older children [26] there did not appear to be any-
thing clearly different about these two infants, though
further work with larger samples is required to investigate
this question fully. Further, it is important to note that in
the present study there was remarkable consistency in the
domains most affected across individual infants. For ex-
ample, motor skills were delayed in almost all infants. Our
findings are consistent with the proposal that infants with
genetic syndromes may show somewhat more consistent
profiles than infants with other routes to ASD, providing
one way to constrain heterogeneity. Further, the observa-
tion of motor delays supports preclinical observations of a
critical role for NF1 in musculoskeletal development [54].
Other limitations were that our comparison infants were
slightly younger than infants with NF1, but we controlled
for age in all analyses. Further, we did not have contextual
data on the ITSP and social engagement scales from other
cohorts, and thus, the interpretability of these measures is
limited to the qualitative case reports.
Conclusions
At 10 months, infants with NF1 in the present study
showed delays in motor and communication functioning,
with milder difficulties in visual reception. Seven out of
ten infants showed atypicality in at least one domain of
sensory function. In contrast, temperament and social
engagement appear relatively typical. This profile shares
some similarity with infants from familial risk samples
who develop ASD, where very early behavioural difficulties
are typically observed in sensory and motor domains
(rather than social functioning). Our work introduces a
new route to establishing a translational developmental
neuroscience of ASD. Prospective longitudinal studies of
infants with neurofibromatosis hold great promise for illu-
minating the neurodevelopmental systems that mediate
between genetic risk and later behavioural symptoms. Our
findings reveal a distinct profile of early impairment that
will be of substantial interest to work on animal models of
ASD. Further, our work indicates the critical importance
of careful developmental monitoring of infants with NF1.
Early delays should be identified and appropriate interven-
tion provided.
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